Skip to content
10-Q

Quarterly Report

KUVATRIS THERAPEUTICS, INC.

0001558370-24-012929

← back to feed
Filed
Sep 20, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Sep 20, 2024 10.88M sh
Shares Diluted Q2 2024 · Jun 30, 2024 7.66M sh
Shares Diluted Q2 2024 · Jun 30, 2024 7.54M sh
Shares Diluted restated Q2 2024 · Jun 30, 2023 860.72K sh
Shares Diluted restated Q2 2024 · Jun 30, 2023 802.37K sh
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$4.37M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$5.82M
Short Term Investments Q2 2024 · Jun 30, 2024 $0
Short Term Investments Q2 2024 · Dec 31, 2023 $0
Stockholders Equity Q2 2024 · Jun 30, 2024 −$1.81M
Stockholders Equity Q2 2024 · Mar 31, 2024 $1.19M
Stockholders Equity Q2 2024 · Dec 31, 2023 $3.39M
Stockholders Equity Q2 2024 · Jun 30, 2023 $2.27M
Stockholders Equity Q2 2024 · Mar 31, 2023 $2.53M
Stockholders Equity Q2 2024 · Dec 31, 2022 $108.8K
Current Liabilities Q2 2024 · Jun 30, 2024 $2.11M
Current Liabilities Q2 2024 · Dec 31, 2023 $1.8M
Total Liabilities Q2 2024 · Jun 30, 2024 $2.61M
Total Liabilities Q2 2024 · Dec 31, 2023 $2.3M
Current Assets Q2 2024 · Jun 30, 2024 $799.61K
Current Assets Q2 2024 · Dec 31, 2023 $5.68M
Total Assets Q2 2024 · Jun 30, 2024 $799.61K
Total Assets Q2 2024 · Dec 31, 2023 $5.68M
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.39
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.89
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$4.05
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$9.12
Eps Basic Q2 2024 · Jun 30, 2024 −$0.39
Eps Basic Q2 2024 · Jun 30, 2024 −$0.89
Eps Basic restated Q2 2024 · Jun 30, 2023 −$4.05
Eps Basic restated Q2 2024 · Jun 30, 2023 −$9.12
Sga Expense Q2 2024 · Jun 30, 2024 $1.49M
Sga Expense Q2 2024 · Jun 30, 2024 $4.79M
Sga Expense Q2 2024 · Jun 30, 2023 $2.77M
Sga Expense Q2 2024 · Jun 30, 2023 $6.58M
Rd Expense Q2 2024 · Jun 30, 2024 $1.51M
Rd Expense Q2 2024 · Jun 30, 2024 $1.9M
Rd Expense Q2 2024 · Jun 30, 2023 $589.03K
Rd Expense Q2 2024 · Jun 30, 2023 $811.52K
Net Income Q2 2024 · Jun 30, 2024 −$3M
Net Income Q2 2024 · Jun 30, 2024 −$6.69M
Net Income Q2 2024 · Jun 30, 2023 −$3.49M
Net Income Q2 2024 · Jun 30, 2023 −$7.32M
Operating Income Q2 2024 · Jun 30, 2024 −$3M
Operating Income Q2 2024 · Jun 30, 2024 −$6.69M
Operating Income Q2 2024 · Jun 30, 2023 −$3.36M
Operating Income Q2 2024 · Jun 30, 2023 −$7.39M